Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
265
datasets available to search
ShareScore release 0.9.0
Dataset results
265 results for “Aromatase inhibitors”
A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuv
ClinicalTrials.gov study NCT02413008. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure
ClinicalTrials.gov study NCT00555477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
ClinicalTrials.gov study NCT06307457. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
ClinicalTrials.gov study NCT02246621. IPD Sharing: YES. Countries: 22. Publications: 6.
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00485953. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT04268134. IPD Sharing: NO. Countries: 1. Publications: 2.
Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor
ClinicalTrials.gov study NCT05361655. IPD Sharing: NO. Countries: 1. Publications: 6.
Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone
ClinicalTrials.gov study NCT05012644. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)
ClinicalTrials.gov study NCT01129622. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
ClinicalTrials.gov study NCT01298362. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00754845. IPD Sharing: NO. Countries: 2. Publications: 4.
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
ClinicalTrials.gov study NCT00570921. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain
ClinicalTrials.gov study NCT01028352. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT02756364. IPD Sharing: YES. Countries: 2. Publications: 0.
Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT01437566. IPD Sharing: Not stated. Countries: 23. Publications: 1.
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment
ClinicalTrials.gov study NCT02946684. IPD Sharing: NO. Countries: 1. Publications: 2.
Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
ClinicalTrials.gov study NCT02910050. IPD Sharing: NO. Countries: 1. Publications: 13.
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
ClinicalTrials.gov study NCT02530411. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06650423. IPD Sharing: UNDECIDED. Countries: 0. Publications: 23.
Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients
ClinicalTrials.gov study NCT01809171. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.